Haemonetics Corp. buy Barrington Research
Start price
13.02.24
/
50%
€66.00
Target price
13.02.25
€97.90
Performance (%)
21.97%
Price
25.04.24
€80.50
Summary
This prediction is currently active. The prediction currently has a performance of 21.97%. This prediction currently runs until 13.02.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | 6.623% | 6.623% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Barrington_Research for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $105.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Barrington_Research for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€81.50
03.11.23
03.11.23
€97.80
03.11.24
03.11.24
-1.23%
25.04.24
25.04.24
